Farmacie pro praxi. 2023;19(2):86-90

Performance­‑enhancing drugs: an overview for pharmacy practice

Miroslav Turjap1, Michal Turjap1, Jan Juřica2, 3
1 Lékárna FN Ostrava, Ostrava
2 Masarykova univerzita, Farmakologický ústav, Lékařská fakulta a Ústav farmakologie a toxikologie, Farmaceutická fakulta, Brno
3 Ústavní lékárna, Masarykův onkologický ústav, Brno

By doping, we usually mean the use of prohibited substances by an athlete for performance enhancement. Officially, it is a violation of the anti-doping rules specified in the World Anti-Doping Code. The article presents a brief overview of human medicines available in the Czech Republic that contain substances from the List of Prohibited Substances and Methods of the World Anti-Doping Agency (WADA). Examples of doping affairs of professional athletes are presented.

Keywords: performance­‑enhancing drugs, doping, WADA, Czech Anti­‑Doping Committee.

Accepted: May 29, 2023; Published: June 7, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Turjap M, Turjap M, Juřica J. Performance­‑enhancing drugs: an overview for pharmacy practice. Pharmacy for Practice. 2023;19(2):86-90.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Antidopingový výbor ČR. Definice dopingu [Internet] Cited 9. 1. 2023. Available from:https://www.antidoping.cz/cs/co­‑je­‑to­‑doping.
    2. World Anti­‑Doping Agency (WADA) [Internet] Cited 9. 1. 2023. Available from: https://www.wada­‑ama.org/en/prohibited­‑list#search­‑anchor.
    3. Kam PCA, Yarrow M. Anabolic steroid abuse: physiological and anaesthetic considerations. Anaesthesia. 2005;60(7):685-92. Go to original source... Go to PubMed...
    4. Baggish AL, Weiner RB, Kanayama G, et al. Cardiovascular Toxicity of Illicit Anabolic­‑Androgenic Steroid Use. Circulation. 2017;135(21):1991-2002. Go to original source... Go to PubMed...
    5. Pope HG, Jr., Wood RI, Rogol A, et al. Adverse Health Consequences of Performance­‑Enhancing Drugs: An Endocrine Society Scientific Statement. Endocrine Reviews. 2014;35(3):341-75. Go to original source... Go to PubMed...
    6. SPC LADYBON [Internet] Cited 9. 1. 2023. Available from: https://www.sukl.cz/modules/medication/download.php?file=SPC163699.pdf & type=spc & as=ladybon­‑spc
    7. SPC DANATROL [Internet]. Cited 9. 1. 2023. Available from: https://www.sukl.cz/modules/medication/download.php?file=SPC162596.pdf & type=spc & as=danatrol­‑spc.
    8. SPC ISTURISA [Internet]. Cited 9. 1. 2023. Available from: https://www.ema.europa.eu/en/documents/product­‑information/isturisa­‑epar­‑product­‑information_cs.pdf.
    9. Kamalakkannan G, Petrilli CM, George I, et al. Clenbuterol increases lean muscle mass but not endurance in patients with chronic heart failure. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2008;27(4):457-61. Go to original source... Go to PubMed...
    10. Davis E, Loiacono R, Summers RJ. The rush to adrenaline: drugs in sport acting on the beta­‑adrenergic system. British Journal of Pharmacology. 2008;154(3):584-97. Go to original source... Go to PubMed...
    11. Zinser L, Schmidt MS. Jones Admits to Doping and Enters Guilty Plea [Internet]. Cited 9. 1. 2023. Available from: https://www.nytimes.com/2007/10/06/sports/othersports/06balco.html.
    12. Schwarz S, Onken D, Schubert A. The steroid story of Jenapharm: from the late 1940 s to the early 1970 s. Steroids. 1999;64(7):439-45. Go to original source... Go to PubMed...
    13. International Olympic Commitee. Sochi 2014 re­‑analysis and investigations. IOC sanctions five Russian athletes and publishes first full decision as part of the Oswald Commission findings [Internet]. Přístup 9. 1. 2023. Available from: https://stillmed.olympic.org/media/Document%20Library/OlympicOrg/IOC/Who­‑We­‑Are/Commissions/Disciplinary­‑Commission/2017/SML-006-Decision­‑Alexander­‑LEGKOV.pdf.
    14. Wikipedia. Doping at the Olympic Games [Internet]. Cited 9. 1. 2023. Available from: https://en.wikipedia.org/wiki/Doping_at_the_Olympic_Games#1992_Barcelona.
    15. Wikipedia. Doping at the Tour de France [Internet]. Cited 9. 1. 2023. Available from: https://en.wikipedia.org/wiki/Doping_at_the_Tour_de_France.
    16. SPC EVRENZO [Internet]. Cited 9. 1. 2023. Available from: https://www.ema.europa.eu/en/documents/product­‑information/evrenzo­‑epar­‑product­‑information_cs.pdf.
    17. SPC REBLOZYL [Internet]. Cited 9. 1. 2023. Available from: https://www.ema.europa.eu/en/documents/product­‑information/reblozyl­‑epar­‑product­‑information_cs.pdf.
    18. SPC SAIZEN [Internet]. Cited 9. 1. 2023. Available from: https://www.sukl.cz/modules/medication/download.php?file=SPC181889.pdf & type=spc & as=saizen­‑spc.
    19. Pelley S. The Case of Alex Rodriguez [Internet]. Cited 9. 1. 2023. Available from: https://www.cbsnews.com/news/doping­‑case­‑of­‑alex­‑rodriguez­‑mlb-60-minutes/.
    20. SPC INCRELEX. [Internet] Cited 9. 1. 2023. Available from: https://www.sukl.cz/modules/medication/detail.php?kod=0029024.
    21. Anderson LJ, Tamayose JM, Garcia JM. Use of growth hormone, IGF­‑I, and insulin for anabolic purpose: Pharmacological basis, methods of detection, and adverse effects. Molecular and Cellular Endocrinology. 2018;464:65-74. Go to original source... Go to PubMed...
    22. Pluim BM, de Hon O, Staal JB, et al. β₂-Agonists and physical performance: a systematic review and meta­‑analysis of randomized controlled trials. Sports Medicine (Auckland, NZ). 2011;41(1):39-57. Go to original source... Go to PubMed...
    23. Riiser A, Stensrud T, Stang J, et al. Aerobic performance among healthy (non­‑asthmatic) adults using beta2-agonists: a systematic review and meta­‑analysis of randomised controlled trials. British Journal of Sports Medicine. 2021;55(17):975-83. Go to original source... Go to PubMed...
    24. SPC PREDUCTAL [Internet]. Cited 9. 1. 2023. Available from: https://www.sukl.cz/modules/medication/download.php?file=SPC173114.pdf & type=spc & as=preductal­‑mr­‑spc.
    25. Stuart M, Schneider C, Steinbach K. Meldonium use by athletes at the Baku 2015 European Games. British Journal of Sports Medicine. 2016;50(11):694-8. Go to original source... Go to PubMed...
    26. Sanchis­‑Gomar F, Martínez­‑Bello VE, Derbré F et al. Rapid hemodilution induced by desmopressin after erythropoietin administration in humans. Journal of Human Sport and Exercise. 2011;6:315-22. Go to original source...
    27. Baron D. Prohibited non­‑hormonal performance­‑enhancing drugs in sport. In: UpToDate, Fricker P, editor. Přístup 9. 1. 2023. [online, subscription required] Uptodate, Waltham, MA, 2022.
    28. Baltazar­‑Martins JG, Plata MDM, Muñoz­‑Guerra J, et al. Infographic. Tramadol: should it be banned in athletes while competing, particularly in road cycling? British Journal of Sports Medicine. 2020;54(2):120-1. Go to original source... Go to PubMed...
    29. Mauger A, Thomas T, Smith S. Is tramadol a performance enhancing drug? A randomised controlled trial. Presentation at British Association of Sport and Exercise Medicine Conference, 26-27 May 2022, Brighton, UK Final report available at: https://www.wada­‑ama.org/en/resources/funded­‑scientific­‑research/tramadol­‑performance­‑enhancing­‑drug.
    30. Holgado D, Zandonai T, Zabala M et al. Tramadol effects on physical performance and sustained attention during a 20-min indoor cycling time­‑trial: A randomised controlled trial. Journal of Science and Medicine in Sport. 2018;21(7):654-60. Go to original source... Go to PubMed...
    31. Antidopingový výbor ČR. Statistika dopingových kontrol [Internet]. Cited 9. 1. 2023. Available from: https://www.antidoping.cz/cs/statistiky.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.